Latest News and Press Releases

TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a...

Classiq raised $110 million in Series C funding, the largest ever for a quantum software company. The round was led by Entrée Capital.

 To assist enquiries a copy of the amended complaint can be viewed by clicking the following link:Quantum Amended Court Claim TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd....

Arqit, in collaboration with Equus and Intel, demonstrates a world-first Quantum-Safe CSfC-Compliant MACP Architecture for Classified Mobile Communications

Arqit delivers quantum-safe protection enhanced by confidential computing. Powered by Intel Trust Domain Extensions (Intel TDX) and Arqit NetworkSecure™.

Arqit appoints new Chief Technology Officer to drive innovation and growth

RSG purchases test and integration license from Arqit to deliver quantum-secure networks and prepare for commercial-scale deployment

Global tier 1 telco operator signs three year agreement with Arqit to secure its Quantum-Safe Network-as-a-Service (NaaS) Deployment

Defiance Launches RGTX: 2X Leveraged ETF for Rigetti Computing, Inc.

TORONTO, March 31, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”) is pleased to announce that it has closed the final...